News

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...
When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.
According to New Danish research, the ancient Chinese acupuncture practice may come to the rescue for women struggling with menopausal symptoms, such as hot flashes or night sweats, and might bring ...
Black cohosh root may bring some relief from hot flashes (medically known as vasomotor symptoms or VMS), with potentially fewer side effects than estrogen. Creams made from wild yam extract converted ...
HOT Labs, a leading blockchain innovator known for its multi-chain wallet solution and Chain Abstraction infrastructure, has secured a $250,000 grant from the Stellar Development Foundation (SDF).
As one of the most common symptoms of menopause, hot flashes might also be the most disruptive. From waking up drenched to sweating through clothes by 10 a.m., they’re challenging enough on ...
Blockchain developer HOT Labs has announced that it has exceeded one million active users on its Omni Balance platform. The milestone highlights the growing market preference for Chain Abstraction ...
Embr Labs compares it to how your body might adapt to a steaming hot bath or the cold ocean just by setting foot in the water. Although there are ways to try to manage hot flashes, there is not ...
San Francisco, California, May 13th, 2025, Chainwire Blockchain developer HOT Labs has announced that it has exceeded one million active users on its Omni Balance platform. The milestone highlights ...
Bunsen never married, instead choosing to live for his students and his laboratory, setting up an excellent lab and remaining popular with his pupils throughout. Bunsen was first drawn towards ...
Sleep disturbances not explained by other causes Unexplained fatigue or mood changes Occasional hot flashes or night sweats, even while still menstruating Vaginal dryness or decreased lubrication ...